Cecile Jacoby joins Q1 Scientific as General Manager in Belgium

Q1 Scientific, which offers environmentally controlled stability storage services to the pharmaceutical, medical device and life sciences industries, today announced that Cécile Jacoby has been appointed General Manager at the new Q1 Scientific Belgium facility.

Cecile Jacoby and Stephen Delaney from Q1 Scientific at new Belgium facility
Cecile Jacoby, General Manager and Stephen Delaney, Managing Director pictured at the new Q1 Scientific Belgium facility

With more than 25 years of experience in senior strategic and operations roles across pharmaceutical, vaccine, healthcare and cell therapy companies, Cécile has a proven track record in developing, driving and managing business operations. After working at Director level in GSK for over 10 years, Cécile became a Senior Executive Consultant delivering several worldwide assignments to pharmaceutical, R&D and biotechnology companies. Cécile also took over the general management of a Belgian Biotech group’s subsidiary and an industrial group’s holding company.

On joining Q1 Scientific as General Manager in Belgium, Cécile Jacoby says,

“I am excited to join Q1 Scientific which is part of the supply chain process for a number of the world’s largest pharmaceutical companies. Stability storage and testing are critical components of drug development and new therapy commercialisation. I am looking forward to working alongside the expert team, to further solidify the company’s position in Belgium and across Europe”

Q1 Scientific’s new state-of-the-art temperature-controlled and monitored Belgium storage facility is in the easily accessible Liege region, approximately 50 miles from Brussels. The facility provides 35,000 temperature-controlled storage spaces for all key ICH climatic zones, supporting long-term, intermediate and accelerated stability trials, including 2 – 8°C and 25°C / 60%RH and 40°C / 75%RH.

Commenting on Cécile’s appointment and the new stability storage facility in Belgium Stephen Delaney, Managing Director at Q1 Scientific says,

“Cécile’s deep knowledge of life sciences, and strong commercial and operating focus, make her the ideal leader for Q1 Scientific Belgium as we expand our offering across Europe. Operating two sites will greatly benefit our European customers, who can now expect even faster turnaround times for the return of samples. Meanwhile, we will also be able to provide greater temperature-controlled transport options in mainland Europe. Cécile joins Q1 Scientific at an exciting time for the company and will add tremendous value as we continue to focus on our growth strategy”

Last year, Q1 Scientific was acquired by Cambrex, a leading global contract development and manufacturing organisation (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle. This expansion into Belgium is part of the Cambrex strategy to expand its portfolio of specialised solutions for pharmaceutical development and manufacturing across North America and Europe.

About Q1 Scientific, a Cambrex company

Q1 Scientific, a Cambrex company, was founded in Waterford, Ireland in 2013 by Louise Grubb, and offers environmentally controlled stability storage services to the pharmaceutical, medical device and life sciences industries at their 30,000 sq ft. cGMP facility. As the first company in the sector to establish in Ireland, Q1 Scientific is revolutionizing the way pharmaceutical companies store their products, helping to improve the speed it takes for new drugs to reach the marketplace along with saving companies the expense of building and monitoring their own storage chambers. In June 2022, US company Cambrex acquired Q1 Scientific.